Suomen sivusto, jossa voit ostaa halvalla ja laadukas Viagra http://osta-apteekki.com/ toimitus kaikkialle maailmaan.

Erityisesti laatu viagra tästä kaupasta voi taata henkilökohtaisesti viagra Paras laatu kehotan Teitä miellyttää.

Microsoft word - calhoun_b cv

ELIZABETH ANN CALHOUN, Ph.D.
Home: 2342 West Erie Street, Chicago, IL. 60612
Office: 1603 W. Taylor Street #789, Chicago, IL 60612
Home: 773-862-1701 Office: (312) 355-1572 Fax: (312) 996-5356
Education
The Cost-Effectiveness and Outcomes of Assertive Case Management Community Treatment Programs Targeting Long-Stay Psychiatric Inpatients Across the State of South Carolina.
Professional Experience
Professor and Director, Center of Excellence For the Elimination ofHealth Disparities and Director, Clinical Research Methods Certificate Department of Health Policy and Administration School of Public Health, University of Illinois at Chicago Department of Urology, Institute of Health Services Research and Policy Studies, and Robert H. Lurie Comprehensive Cancer Center, Associate Professor and Senior Research Scientist Department of Health Policy and Administration School of Public Health, University of Illinois at Chicago Assistant ProfessorDepartment of Urology, Institute of Health Services Research and Policy Studies, and Robert H. Lurie Comprehensive Cancer Center, American Schools of Professional Psychology Masters in Health Services Management Program South Carolina State Department of Mental Health Editorial Boards
Grant Reviewer
National Center on Minority Health and Health Disparities Extramural Activities/Committees
Robert H. Lurie Comprehensive Cancer Center, Northwestern Consultant, Alza/Johnson and Johnson/Ortho-Biotech,Inc.
Member, Board of Director, St. Basil’s Free Peoples Clinic Extramural Activities/Committees
Member, Amgen Neutropenia Scientific Advisory Board School of Public Health, University of Illinois at Chicago School of Public Health, University of Illinois at Chicago Member, Health Policy and Administration Faculty Search Committee School of Public Health, University of Illinois at Chicago Member, University of Illinois at Chicago Senate and Research Member, Campus Research Board, University of Illinois at Chicago Member, Translational Research Academy, University of Illinois at Publications
Peer Reviewed Articles
1. Calhoun EA, Bennett CL, Peeples PA, Lurain JR, Roland PA, Weinstein J, and Fishman D.
Perceptions of Cisplatin Related Toxicity Among Ovarian Cancer Patients and Gynecologic Oncologists. Gynecologic Oncology. 1998; 71: 369-375.
2. Bennett CL, Golub R, Calhoun EA, Weinstein J, and Lurain J. Cost-Utility Assessment of
Amifostine as First-Line Therapy for Ovarian Cancer. International Journal of Gynecologic 3. Bach PB, Calhoun EA, and Bennett CL. Prescription Tracking as a Sampling Method for
Survey Research: Report from a Mail Survey of Physicians about HIV Care. Journal of Clinical Epidemiology. 1999; 52, 2:147-150.
4. Bach PB, Calhoun EA, and Bennett CL. The Relation Between Physician Experience and
Patterns of Care for Patients with AIDS-related Pneumocystis Carinii Pneumonia (PCP): Results From A Survey Of 1,500 Physicians in the United States. Chest. 1999; 52:2:147-150.
5. Calhoun EA, and Bennett CL. Pharmacoeconomics of Amifostine in Ovarian Cancer.
Seminars in Oncology. 1999; 26, 2:102-107.
6. Stinson TJ, Calhoun EA, Yang T, Lurain JR, and Bennett CL. Cost Analysis of Second-Line
Therapies for Platinum-Refractory Ovarian Cancer: Reimbursement Dilemmas for Medicare Patients. Cancer Investigation. 1999; 17(8):559-65.
7. Litwin MS, McNaughton-Collins M, Fowler FJ Jr, Nickel JC, Calhoun EA, Pontari MA,
Alexander RB, Farrar JT, and O’Leary MP. The NIH Chronic Prostatitis Symptom Index (NIH-CPSI): Development and Validation of a New Outcomes Measure. Journal of Urology.
8. Nadler RB, Koch AE, Calhoun EA, Campbell PL, Rajan N, Yarnold PR, Bennett CL, and
Schaeffer AJ. Cytokine Levels in Men with Chronic Prostatitis Pelvic Pain Syndrome.
Journal of Urology. 2000, July; 164:214-218.
9. Calhoun EA and Bennett CL. Pharmacoeconomics of Amifostine in Oncology. Oncology
10. Dobrez D, Calhoun EA, Fishman D, and Cella D. Assessing Utilities for Use in Cost-
Effectiveness Analyses: The Case of Ovarian Cancer Screening and Treatment. Oncology 11. McNaughton-Collins M, O’Leary MP, Calhoun EA, Pontari MA, Adler A, Eremenco S, Chang
CH, Odom L, Litwin MS, and the Chronic Prostatitis Collaborative Research Network. The Spanish NIH-Chronic Prostatitis Symptom Index: Translation and Linguistic Validation.
Journal of Urology. 2001, Nov; 166(5):1800-3.
12. McNaughton-Collins M, O’Leary MP, Pontari MA, Calhoun EA, Kusek JW, Santanna J,
Landis JR, Litwin MS, and the Chronic Prostatitis Collaborative Research Network. Qualityof Life is Impaired in Men With Chronic Prostatitis: Results of the NIH Cohort Study Boston, MA; Los Angeles, CA; Chicago, IL; Bethesda, MD; Philadelphia, PA. J General Internal Medicine. 2001; 16:656-662.
13. Calhoun EA, Welshman EE, Chang CH, Fishman DA, Lurain JR and Bennett CL. The Costs
Associated with Chemotherapy-Induced Toxicities. The Oncologist. 2001; 6:8:441-445.
14. Grobman WA, Dooley S, Welshman EE, Pergament E, and Calhoun EA. Utility Assessment
of Amniocentesis: Is 35 Years a Rational Cutoff? Northwestern University, Chicago, IL, 60611. American Journal of Obstetrics and Gynecology. 2001; 184: S109.
15. Lindrooth RC, Calhoun EA, Welshman EE, and Budetti P. Quality Management Techniques
at Academic Medical Centers: Results from a National Survey. Journal of Quality Health 16. Calhoun EA, and Bennett CL. Evaluating the Total Costs of Cancer. The Northwestern
University Costs of Cancer Program. Oncology. 2003 Jan; 17(1):109-14; discussion 119-21.
17. Grobman WA, Welshman EE, and Calhoun EA. Does Fetal Fibronectin Use in the Diagnosis
of Preterm Labor Affect Physician Behavior and Health Care Costs? A Randomized Trial.
Am J Obstetrics & Gynecology. 2004 Jul;191(1):235-40.
18. Calhoun EA, Chang CH, and Cella, DF. Psychometric Evaluation of the Functional
Assessment of Cancer Therapy Scales for Patients with Neurotoxicity from Systemic Chemotherapy (FACT-NTX). Gynecologic Oncology. 2003; 13,741-748.
19. Calhoun EA, Fishman DA, Lurain JR, and Roland PY. Comparison of Ovarian Cancer
Treatments: Analysis of Utility Assessments of Patients, At-Risk Populations, General Population, & Physicians. Gynecologic Oncology. 2004; 93: 164-169.
20. Calhoun EA, McNaughton-Collins M, Pontari MA, O’Leary MP, Leiby BE, Landis JR, Kusek
JW, Litwin MS, and the Chronic Prostatitis Collaborative Research Network. The Economic Impact of Chronic Prostatitis. Archives of Internal Medicine. 2004; 164(11):1231-6.
21. Arozullah AM, Calhoun EA, Wolf M, Finley DK, Fitzner KA, Heckinger EA, Gorby NS,
Schumock GT, and Bennett CL. The Financial Burden of Cancer: Estimates from a Study of Insured Women with Breast Cancer. Journal of Supportive Oncology. 2 (3) 271-283.
22. Dobrez D and Calhoun EA. Testing Subject Comprehension of Utility Questionnaires. Quality
of Life Research. 2004; 13 Issue 2, 369-376.
23. Bennett CL and Calhoun EA. Pharmacoeconomics of Liposomal Anthracycline Therapy.
Seminars in Oncology. 2004, Dec; 31(6 Suppl 13):191-5. 24. Cosler LE, Calhoun EA, Agboola O, and Lyman GH. Effects of Indirect and Additional
Direct Costs on the Risk Threshold for Prophylaxis with Colony-Stimulating Factors in Patients At Risk for Severe Neutropenia from Cancer Chemotherapy. Pharmacotherapy.
2004; Apr; 24(4):488-94.
25. Clemens JQ, Meenan RT, O’Keeffe Rosetti M, Gao SY, and Calhoun EA. Prevalence and
Incidence of Interstitial Cystitis in a Managed Care Population. Journal of Urology, 2005.
26. Wei JT, Calhoun EA, and Jacobsen SJ. Urologic Diseases in America: Begin Prostatic
Hyperplasia. Journal of Urology. 2005, Apr; 173(4):1256-61.
27. Stothers L, Thom D, and Calhoun, EA., Urologic Diseases in America: Urinary Incontinence
in Men. Journal of Urology. 2005, Apr; 173(4):1302-1308.
28. Nygaard I, Thom D, and Calhoun EA. Urologic Diseases in America Project: Urinary
Incontinence in Women-National Trends in Hospitalizations, Office Visits, Treatment, and Economic Impact. Journal of Urology. 2005, April; 173(4):1295-1301.
29. Pearle MS, Calhoun EA, and Curhan GC. Urologic Diseases in America: Urolitaisis. Journal
of Urology. 2005, Mar; 173(3):848-57.
30. Pontari MA, McNaughton-Collins M, O'Leary MP, Calhoun EA, Jang T, Knauss J, Kusek
JW, Landis JR, Litwin MS, and the CPCRN Study Group. A Case-Control Study of Risk Factors in Men with Chronic Pelvic Pain Syndrome, Philadelphia, PA. British Journal of Urology. 2005, Sept; 96(4): 559-565.
31. McNaughton-Collins M, Wang Y, Propert KJ, Alexander R, Calhoun EA, Nickel JC, O’Leary
MP, Pontari M, Litwin MS, and the Chronic Prostatitis Collaborative Research Network (CPCRN). Responsiveness to Change over Time of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) and the Amount of Change Clinically Perceptible to Patients. Quality of Life Research. Vol 12:2: 2006, Mar; 299-305.
32. Matthews AK, Berrios N, Darnell JS, and Calhoun EA. A Qualitative Evaluation of a Faith-
Based Breast and Cervical Cancer Screening Intervention for African American Women.
Health Education and Behavior. 2006 Oct; 33(5):643-63; 2006 Jul 21.
33. Clemens JQ, Meenan R, O’Keeffe Rosetti MC, Gao SY, Calhoun EA. Prevalence of
interstitial cystitis symptoms in a managed care population. Journal of Urology. 2005; 173: 34. Clemens JQ, Meenan R, O’Keeffe Rosetti MC, Gao SY, Calhoun EA. Incidence and clinical
characteristics of NIH type III prostatitis in the community. Journal of Urology. 2005; 35. Calhoun EA, Schumock GT, McKoy JM, Pickard S, Fitzner KA, Heckinger EA, Powell E F,
McCaffrey KR, Bennett CL. G-CSF for Chemotherapy-Induced Neutropenia in Patients with Small Cell Lung Cancer: The 40% Rule Revisited. Pharmacoeconomics. 2005; 23 (8): 767-775.
36. Clemens JQ, Meenan R, O’Keeffe Rosetti MC, Gao SY, Brown SO, and Calhoun EA.
Prevalence of Prostatitis-Like Symptoms in a Managed Care Population. Journal of Urology.
37. Clemens JQ, Broen SO, Kozloff L, and Calhoun EA. Predictors of Symptom Severity in
Patients with Chronic Prostatitis and Interstitial Cystitis. Journal of Urology. 2006, Mar; 38. Darnell J, Chang CH, and Calhoun EA. Knowledge About Breast Cancer and Participation in
a Faith-Based Breast Cancer Program and Other Predictors of Mammography ScreeningAmong African Americans and Latinas. Health Education and Behavior. 2006, Oct; 33(5): 39. Shapiro L, Thompson D, and Calhoun EA. Sustaining a Safety Net Breast and Cervical
Cancer Detection Program. Journal of the Underserved and Poor. 2006, July; 7(2):20-30.
40. Wolf MS, Satterlee M, Calhoun EA, Skripkauskas S, Fulwiler D, Diamond-Shapiro L, Alvarez
H, Eder M, and Mukundan P. Colorectal Cancer Screening Among the Medically Underserved. J Health Care Poor Underserved. 2006, Feb; 17(1):47-54.
41. Wagner LI, Beaumont JL, Beiying D, Malin J, Peterman A, Calhoun EA, and Cella D.
Measuring Health-Related Quality of Life and Neutropenia-Specific Concerns Among Older Adults Undergoing Chemotherapy: Validation of the Functional Assessment of Cancer Therapy – Neutropenia (FACT-N). Supportive Care in Cancer. 2008, Jan; 16(1):47-56.
42. Bennett CL and Calhoun EA. Evaluating the Total Costs of Chemotherapy-Induced Febrile
Neutropenia: Results from a Pilot Study with Community Oncology Cancer Patients.
43. Anna MS, Duloy BE, Calhoun EA, and Clemens JQ. The Economic Impact of Chronic
Prostatitis. Curr Urol. Rep. Review 2007, July; 8(4):336-9.
44. Dedhia RC, Calhoun EA, and McVary KT. Impact of Phytotherapy on Utility Scores for 5
Benign Prostatic Hyperplasia/Lower Uninary Tract Symptoms Health States. Journal of Urology. 2008, Jan; 179 (1): 200-225.
45. Clemens JQ, Meenan R, O’Keeffe Rosetti MC, Gao SY and Calhoun EA. Prevalence and Risk
Factors for Prostatitis: Population-Based Assessment Using Physician-Assigned Diagnoses.
Journal of Urology. 2007, Oct; 178 (4) 1333-1337.
46. Clemens JQ, Meenan R, O’Keeffe Rosetti MC, Gao SY and Calhoun EA. Overlap of Voiding
Symptoms, Storage Symptoms and Pain in Men and Women. Journal of Urology. 2007, 47. Clemens JQ, Meenan RT, O’Keeffe Rosetti MC, Kimes TA, and Calhoun EA. A Case Control
Study of Medical Co-Morbidities in Women with Interstitial Cystitis. Journal of Urology.
48. Patel R, Calhoun EA, Meenan RT, O’Keefe Rosetti MC, Kimes T, and Clemens JQ. Costs of
Interstitial Cystitis in a Managed Care Population. Journal of Urology. 2008, May;71(5):776- 49. Clemens JQ, Meenan RT, O’Keeffe Rosetti MC, Kimes TA, and Calhoun EA. Incidence and
Clinical Characteristics of Interstitial Cystitis in the Community. International 50. Calhoun EA, Clemens JQ, Litwin MS, Walker-Corkery E, Markossian T, and McNaughton-
Collins M. Primary Care Physician Practice Patterns in the Management of Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome, in press. Prostate Cancer and Prostatic 51. Clemens JQ, Brown SO, and Calhoun EA. Mental Health Diagnoses in Patients with
Interstitial Cystitis/Painful Bladder Syndrome and Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Case/Control Study. Journal of Urology. 2008 Oct; 180(4):1378-82.
52. Calhoun EA, Whitley EM, Esparza A, Ness E, Greene A, Garcia R, and Valverde PA. A
National Patient Navigator Training Program. Health Promotion and Practice. 2008, Dec; 53. Clemens JQ and Calhoun EA. Comparison of the Economic Impact of Chronic
Prostatitis/Chronic Pelvic Pain Syndrome and Interstitial Cystitis/ Painful Bladder Syndrome. Journal of Urology, 2009, Apr; 73 (4): 743-6.
54. Nonzee NJ, Dandade NA, Markossian T, Agulnik M, Argiris A, Patel JD, Kern RC, Munshi HG, Calhoun EA, and Bennet CL. Evaluating the Supportive Care Costs of Severe
Radiochemotherapy-Induced Mucositis and Pharyngitis: Results from a Northwestern University Costs of Cancer Program Pilot Study with Head and Neck and Non-Small Cell Lung Cancer Patients Who Received Care at a County Hospital, a VA Hospital, or a Comprehensive Cancer Care Center. Cancer. 2008, Sep 15;113(6):1446-52.
55. Freund KM, Battaglia TA, Calhoun EA, Dudley DJ, Fiscella K, Paskett E, Raich PC, and
Roetzheim RG. The Patient Navigation Research Program. Cancer. 2008, Dec 56. Wells KJ, Battaglia TA, Dudley DJ, Garcia R, Green A, Calhoun EA, Mandelbatt JS,
Paskett ED, Patierno SR, Raich PC, Roetzheim RG. Patient Navigation: State of the Art, or is it Science? Cancer. 2008, Oct 15;113(8):1999-2010. Review 57. Nickel JC, Krieger JN, McNaughton-Collins M, Anderson RU, Pontari M, Shoskes DA, Litwin MS, Alexander RB, White PC, Berger R, Nadler R, O’Leary M, Liong ML, Zeitlin S, Chuai S, Landis JR, Kusek JW, Nyberg LM, Schaeffer AJ and Chronic Prostatitis Collaborative Research Network. Alfuzosin and Symptoms of Chronic Prostatitis-Chronic Pelvic Pain Syndrome. New England Journal of Medicine. 2008, Dec; 18;359(25):2663-73.
58. Clemens JQ, Meenan RT, O'Keeffe Rosetti MC, Kimes TA, and Calhoun EA. Case-Control
Study of Medical Comorbidities in Women with Interstitial Cystitis. Journal of Urology.
59. Clemens JQ, Meenan RT, O’Keeffe Rosetti MC, Kimes TA and Calhoun EA. Costs of
Interstitial Cystitis in a Managed Care Population. Urology. 2008, May;71(5):776-80; 60. Patel R, Calhoun EA, Meehan RT, O’Keeffe Rosetti MC, Kimes T, and Clemens JQ.
Incidence and Clinical Characteristics of Interstitial Cystitis in the Community. Pelvic Floor Dysfunct. Int Urogynecology J. 2008, Aug;19(8):1093-6.
61. Scales CD Jr, Calhoun EA, Assimos DG, Lingeman JE, Nakada SY, Pearle MS, Kim M,
Byrne TW, and Preminger G. Outcomes of Surgical Therapy for Urinary Lithiasis. underreview Annals of Internal Medicine.
62. Wallner LP, Porten S, Meenan RT, O’Keeffe Rosetti MC, Calhoun EA, Sarma AV and
Clemens JQ. Prevalence and Severity of Undiagnosed Urinary Incontinence in Women. In 64. Alam M, Hah RJ, Kim JYS, Havey J, White LE, Markossian TW, Ciurea A, and Calhoun
EA. Quality of Life and Utilities Associated with Nonmelanoma Skin Cancer: An Interview-
Based Survey Study, in press, Archives of Dermatology.
65.Parker VA, Clark JA, Leyson J, Calhoun EA, Carroll JK, Freund K, and Battaglia T. Patient
Navigation: Development of a Protocol for Describing What Navigators Do. In press, 66. Clemens JQ, Calhoun EA, Litwin MS, McNaughton-Collins M, Kusek JW, Crowley E M, and
Landis JR for the Urologic Pelvic Pain Collaborative Research Network. Validation of a Modified National Institutes of Health Chronic Prostatitis Symptom Index to Assess Genitourinary Pain in Both Men and Women. In press, Urology.
67. Clemens JQ, Calhoun EA, Litwin MS, McNaughton-Collins M, Dunn RL, Crowley EM, and
Landis JR for the Urologic Pelvic Pain Collaborative Research Network. Rescoring the NIH Chronic Prostatitis Symptom Index (NIH-CPSI): Nothing New. In press, Prostate Cancer 68. Rauscher GH, Ferrans CE, Kaiser K, Campbell R, Calhoun EA, and Warnecke RB.
Misconceptions about Breast Lumps and Delayed Medical Presentation in Urban Breast Cancer Patients, Under review, Cancer.
69. Clemens JQ, Calhoun EA, Litwin MS, Walker-Corkery E, Markossian T, Kusek JW, and
McNaughton-Collins M. Primary Care Physician Practices in the Diagnosis and Management of Women with Interstitial Cystitis/Painful Bladder Syndrome for the Urologic Pelvic Pain Collaborative Research Network. Prostate Cancer & Prostatic Diseases. 12(3):288-95, 2009 70. Risendal B, Whitley E, Valverde P, Guenther-Kellar Y, Oreilly L, Calhoun EA, Esparza A
for the Patient Navigator Training Collaborative (group citation). Implications of Competencies and Training Issues on the Dissemination of Patient Navigation Interventions. Under review, American Journal of Public Health.
71. Beyond the Black-Box: Drug and device- associated Hypersensitivity Events Dennis Raisch PhD, Elizabeth A Calhoun PhD, Olatokunbo S Adegboro BA, Charles L Bennett MD PhD 72. Prevalence of Idiopathic Urinary Incontinence in Men and Women in a U.S. Managed Care Population Lauren P. Wallner, Sima Porten, Richard T. Meenan, Maureen C. O’Keefe Rosetti, Elizabeth A. Calhoun, Aruna V. Sarma, J. Quentin Clemens. Under review, Journal Chapters
1. Cella D, Calhoun EA, and Roland P. Quality of Life Among Women with Gynecologic
Malignancies. Gynecologic Oncology Principals and Practice, 3rd Edition, Lippincott Williams 2. Wei JT, Calhoun, EA and Jacobsen, SJ. Urologic Diseases in America: Begin Prostatic
Hyperplasia. Compendium to United States Congress.
3. Stothers L, Thom D and Calhoun EA. Urologic Diseases in America: Urinary Incontinence in
Men, Compendium to United States Congress.
4. Nygaard I, Thom D, and Calhoun EA. Urologic Diseases in America: Urinary Incontinence in
Women, Compendium to United States Congress.
5. Pearle MS, Calhoun EA and Curhan GC. Urologic Diseases in America: Urolitaisis. In press,
Compendium to United States Congress.
6. Calhoun EA, Anna MS, Duloy BE, and Clemens JQ. The Quality of Life and Economic
Impact of Chronic Prostatitis. Chronic Prostatitis, Humana Press; 2007.
7. Calhoun EA, Duloy BE. AMS: Health Literacy, in Ross Mullner (Ed): Encyclopedia of Health
Services Research. SAGE Reference Project, in press.
8. Calhoun EA, Duloy BE. AM: National Disparities Report, in Ross Mullner (Ed):
Encyclopedia of Health Services Research. SAGE Reference Project, in press.
Conference Proceedings
1. Comparison of Health State Utilities Between Ovarian Cancer Patients and Physicians.
Calhoun EA, Weinstein JA, Lurain JR, Fishman DA, Bennett CL. Society of Gynecologic 2. Considerations for Evaluating the Cost-Effectiveness of Chemoprotective Agents in Oncology.
Pajeau TS, Lane D, Calhoun EA, Golub RM, and Bennett CL. 2nd Annual National VA 3. Health State Utility Assessments: A Comparison of Ovarian Cancer Patients and Their Treating Physicians. Calhoun EA, Weinstein J, Bennett CL, Lurain JL, and Fishman DA.
4. Cost-Utility Assessment of Amifostine in First-Line Therapy for Ovarian Cancer. Fishman D, Calhoun EA, Golub R, Weinstein J, Lurain J.
5. Roland P, Medio F, Bennett CL. American Society of Clinical Oncology 1998.
6. Comparison of Ovarian Cancer Patients’ and Gynecologic Oncologists’ Utility Scores Regarding Chemotherapy-Induced Toxicities. Calhoun EA, Bennett CL, Lurain J, Weinstein J, and Fishman D. American Society of Clinical Oncology 1998.
7. The Chicago Scorecard Project for In-Hospital Tuberculosis Care in 1995 to 1997: Pass or Fail? Bennett CL, Yarnold P, Schwartz D, Bhattacharya M, Calhoun EA, Lane D, Weinstein J, and Weinstein R. World AIDS 1998.
8. The Relation Between In-Hospital TB and PCP Experience and Quality of HIV-Related Tuberculosis Care. Schwartz D, Lane D, Calhoun EA, Bhattacharya M, Weinstein R, Phair J, Yarnold P, and Bennett CL. World AIDS 1998.
9. Geographic variations in in-hospital mortality for HIV-related Pneumocystis carinii pneumonia from Chicago, Los Angeles, New York, and Miami: 1995- 1997. Calhoun EA, Yarnold P, Lane D, Schwartz D, Weinstein R, Phair J, DeHovitz J, Curtis R, Miles S, Dickinson G, and Bennett CL. World AIDS 1998.
10. Cost of Chemotherapy-Induced Hematologic Toxicity. Calhoun EA, Fishman DA, Lurain JR, Roland PY, Bennett CL, and Peeples PA. American Society of Hematology 1998.
11. Cost of Chemotherapy-Induced Hematologic and Neurologic Toxicity. Calhoun EA, Fishman DA, Lurain JR, Roland PY, and Bennett CL. American Society of Clinical Oncology 1999.
12. Quality Management Techniques at Academic Medical Centers: Results from a National Survey. Calhoun EA and Lindrooth RC. Association for Health Services Research, 2000.
13. Direct and Indirect Costs of Chemotherapy-Induced Toxicity. Calhoun EA, Fishman DA, Lurain JR, Roland PY, and Bennett CL. International Society for Pharmacoeconomics andOutcomes Research 1999.
14. Quality Management Techniques at Academic Medical Centers: Results from a National Survey Convenience is the main reason why ovarian cancer patients prefer oral regimen.
Calhoun EA and Roland PY. International Society for Pharmacoeconomics and Outcomes 15. Validity and selective sensitivity of the FACT/GOG-Ntx. Calhoun EA, Fishman DA, Roland PY, Lurain JR, Chang C-H, and Cella D. American Society of Clinical Oncology 2000.
16. Quality of life is impaired in men with chronic prostatitis: results of the NIH cohort study.
McNaughton-Collins M, O’Leary MP, Litwin MS, Pontari MA, Calhoun EA, Kusek JW, Santanna J, and Landis JR. American Urologic Association, 2000.
17. The Economic Impact of Chronic Prostatitis. Calhoun EA, Chicago, IL; McNaughton-Collins M, O’Leary MP, Boston, MA; Pontari MA, Philadelphia, PA; Santanna J, Landis JR, Philadelphia, PA; Litwin MS, Los Angeles, CA; and the Chronic Prostatitis Collaborative Research Network (CPCRN), American Urologic Association 2002.
18. Faith Based Community Action To Promote Early Breast and Cervical Cancer Detection. Darnell J and Calhoun EA American Public Health Association, 2001.
19. Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs?: A randomized trial. Grobman WA, Welshman EE and Calhoun EA.
Northwestern Memorial Hospital, Chicago, IL. Society for Maternal-Fetal Medicine, 2002.
20. Development and Validation of the FACT-Neutropenia Calhoun EA, Chang C-H, Welshman EE and Cella D. American Society of Hematology 2001.
21. A Neutropenia-Specific Quality of Life Instrument: Rationale for the Development of the FACT-N. Calhoun EA, Chang C-H, Welshman EE, and Cella D. American Society of Clinical 22. Weininger R, Mullaly K, Quigley J, Wieting G, Lee J, Heckinger B, Calhoun EA, and Bennett CL. Indirect and direct costs associated with a febrile neutropenic event. Proc Am 23. Stothers L, Thom D and Calhoun EA. Urinary incontinence in men: national trends in health care resource utilization and economic impact. In Litwin MS, Saigal CS, eds. Urologic 24. Relationship between objective and subjective assessments of erectile dysfunction. Calhoun, EA, Welshman EE, Cashy JM, Cella DF, and McVary KT. American Urologic Association2004.
25. Calhoun EA, Darnell J, Birkby G. REACH OUT: A Faith-Based Approach to Breast and Cervical Cancer Education 9th Biennial Symposium on Minorities, the Medically Underserved 26. Darnell J, Birkby G, Calhoun EA. REACH OUT: A Faith-Based Alternate Breast and Cervical Cancer Curriculum 9th Biennial Symposium on Minorities, the Medically 27. REACH OUT: A Faith-Based Approach to Breast and Cervical Cancer Education" Darnell J, Chang C-H and Calhoun EA. APHA 2004.
28. Approach to Reduce Racial and Ethnic Disparities in Breast and Cervical Cancer in Chicago. Darnell J, Calhoun EA, Birkby G, and Berrios N. Innovative Approaches to Eliminate Racial and Ethnic Health Disparities University of Michigan Program for Multicultural Health September 15, 2004 Ann Arbor, Michigan.
29. REACH OUT 2010: Faith-Based Community Action to Promote Early Breast and Cervical Cancer Detection" Calhoun EA, Birkby G, Berrios N, and Darnell J. M.H.S.A., A.M.Chronic 30. Clemens JQ, Meenan RT, O’Keeffe Rosetti MC, Gao SY, and Calhoun, EA. Incidence and clinical characteristics of NIH Type III prostatitis in a managed care population. American Urological Association meeting, San Antonio, May 2005.
31. Clemens JQ, Meenan RT, O’Keeffe Rosetti MC, Gao SY, and Calhoun, EA. Medical costs of interstitial cystitis. American Urological Assocation North Central Section meeting. Chicago, 32. Clemens JQ, Meenan RT, O’Keeffe Rosetti MC, Brown, SO, Gao SY, and Calhoun, EA.
Prevalence of interstitial cystitis symptoms in a managed care population. American Urological Association North Central Section meeting, Chicago, Sept 2005.
33. Clemens JQ, Meenan RT, O’Keeffe Rosetti MC, Gao SY, Brown SO, and Calhoun EA.
Prevalence of prostatitis-like symptoms in a managed care population. American Urological Association North Central Section meeting, Chicago, Sept 2005.
34. Clemens JQ, Meenan RT, O’Keeffe Rosetti MC, Gao SY, and Calhoun, EA. Prevalence of physicial-diagnosed prostatitis in a managed care population.
Association North Central Section meeting, Chicago, Sept 2005.
35. Calhoun EA, Meenan RT, O’Keeffe Rosetti MC, Gao SY, Brown SO, and Clemens JQ.
Prevalence of prostatitis-like symptoms in a managed care population. American Urological Association meeting, San Antonio, May 2004.
36. 36. Calhoun EA, Welshman EE, Dean V, Ellison A, and Grobman WA. Grobman. Chicago Adolescent Pregnancy Program (CHAPP): Reducing subsequent pregnancies among adolescents. American Public Health Association, Philadelphia, November 2005.
37. Thompson D, Diamond Shapiro L and Calhoun EA. From Demonstration to State-wide Programming: Faith-based Mobilization for Early Cancer Detection. American Public Health Association, Philadelphia, November 2005.
38. Darnell J and Calhoun EA. Patient navigation in a faith-based setting: Using focus groups to assess program success. American Public Health Association, Boston, November 2006.
39. Calhoun EA, Whitley EM, Esparza A, Ness E, Valverde PA, Greene A, Garcia R. A National Patient Navigator Training Program, American Cancer Society Symposium, New Orleans, Patient Navigation at Work. American Public Health Association, Washington DC, November 2007.
41. Calhoun EA. Patient Navigation: The Team Effect American Public Health Association, 42. Calhoun EA, Whitley EM, Esparza A, Ness E, Valverde PA, Greene A, and Garcia R. A National Patient Navigator Training Program, American Association of Cancer Research: The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved Atlanta, GA November, 2007.
National Center on Minority Health and Health Center of Excellence for the Elimination of Health Disparities The major goals: This study will develop a patient navigation program for lower income patients needing follow-up for positive cancer screening tests.
The UIC Center for Population Health and Health Disparities The major goals: The aims of the proposed renewal of the Center are to address three questions essential to understanding the disparity in stage at breast cancer diagnosis between White women and women of color based on work to date.
Center for Clinical and Translational Science – Community The major goals: The UIC CCTS will establish a geographical and intellectual home for clinical and translational research, and will facilitate the creation of intellectual communities across administrative barriers to bring the remarkable resources available at UIC to bear on important National Institute of Diabetes and Digestive The major goals: The MAPP initiative will examine UCPPS within the context of co-morbidities at the levels of patient phenotype, epidemiology, and basic science.
The major goals: Extend the Patient Navigation model to include social workers and adapt for rural Response Ability Pregnant and Parenting Program The major goals: Reduce subsequent pregnancies for runaway and homeless youth Ethnic Disparity in Breast Cancer: A Natural Experiment in The major goals: This project will assess whether organized intervention driven by community-based action and legislation can change practice and address a health care disparity.
University of Illinois Rural Patient Navigation 1/1/09– Avon Foundation: Measuring What Navigators Do: Task and Social Network Analysis 1/1/07 - 2/28/09 $50,000 Illinois Department of Public Health: Ethnic disparity insymptomatic breast cancer awareness following routine Centers for Disease Control U50 CCU 522166 Racial and Ethnic Approaches to Community Health (REACH 2010) National Institute of Diabetes and Digestive and Kidney Diseases U01 DK65277-02 Chronic Prostatitis Collaborative Research Network1/1/05 – 2/29/08 $800,000 National Institute of Diabetes and Digestive Development and Validation of Urologic Pelvic National Institute of Diabetes and Digestiveand Kidney Diseases 3 U01 DK065277 02S1 Development and Validation of Urologic Pelvic National Institute of Diabetes and Digestive and Kidney Diseases 3 U01 DK06527 02S1Urologic Pelvic Pain and Primary Care 1/1/05 - 2/28/08 $125,000 Amgen SD/01 Versus Neupogen in Cancer Patients: A Randomized Two Period Cross-Over trial. 8/1/03-7/31/05 SPORE NIH CA90386-01Relationship between objective and subjective assessments of erectile dysfunction. 7/1/01-6/30/05$400,000 5APH PA002039-02-0 Chicago Adolescent Parenting Program, a comprehensive, coordinated system of care for pregnant adolescents and their families. OAP 9/1/01-8/30/06 NIDDK DK60177-01 A multi-center study designed to evaluate the incidence and prevalence as well as the risk factors, quality of life and economic impact of chronic pelvic National Institute on Health/Association for Healthcare Research and Quality R01 CA89503-01. A methodological study focusing on the improvement of cost-effectivenessmethods through both the better measurement and use of utilities in CE models, using ovarian cancer screening as a SPORE NIH CA90386-01 Effect of migration on knowledge of prostate cancer amongst Hispanic men living in Cook County, HRSA H97HA00223-01Community Health Outreach Program An outreach program designed to reach the hardest- to-reach individuals living at-risk for HIV in an effort to engage them in primary care. 10/1/01-9/30/03 $800,000 NMPG, Outcomes and process evaluation of the James M.
and Catherine M. Denny Medical Center at the Lawson House NIH DK53730-05 Chronic Prostatitis Collaborative Clinical Amgen, The Impact of Chemotherapy Delay on Quality of Life and Psychological Functioning in Patients with Cancer.
Amgen, The development and validation of the FACT- ALZA, Amifostine as a Toxicity Protectant in Ovarian Cancer A Pilot Phase III Randomized Controlled Trial 7/15/98- ALZA, Cost-Impact, Costs, and Quality of LifeConsiderations in Cancer 2/01/99-8/30/00 $165,000 Us Bioscience, The Impact of Oral Chemotherapy on Quality of life in Patients with Recurrent Epithelial Ovarian Cancer Coleman Foundation, Evaluation of barriers to prostate cancer screening in Latino men, 7/1/02-12/31/02 $10,000 2% CDC, A faith-based health promotion program designed to reduce gaps in breast and cervical cancer screening and early detection (phase I). 2/1/00-8/31/00 $50,000 Coleman Foundation, A pilot study to Test Interview Techniques and Evaluate Respondent Burden. 1/1/99-3/31/99$20,000 ABT Associates Clinical Trials, to describe health care resource utilization in newly diagnosed breast cancer patients Cost-utility assessment of amniocentesis, multiple maker serum screening, and ultrasound in pregnant women seeking prenatal diagnosis. 5/1/99-7/1/00 Donated ALZA Corporation Cost Effectiveness Models of New Drugs in Oncology: Are They Helpful to Policy Makers? 3/1/97- Pediatric Oncology Group Economic Analysis of POG: G- CSF in an Intensive Treatment for T-Cell Leukemia and Advanced Stage Lymphoblastic Lymphoma of Childhood.
Chicago Community Trust a Pilot Study of Quality of In-Hospital Care for Persons with HIV-Related Tuberculosis in Northwestern Memorial Foundation, Quality of Life Assessment for Women with and at Increased Risk for the Development of Ovarian Cancer: Comparisons to “Normal” Women and Their Treating Physicians. 1/1/98-12/31/98 Coleman Foundation Measurement and Use of Utilities in Ovarian Cancer CEA. 1/1/99-3/31/99 $5,000

Source: http://publichealth.uic.edu/media/uicedu/sph/downloads/pdfs/hpa/Calhoun_B,CV.pdf

Press release form

Eisai London Research Laboratories Licenses OriGene’s FlagArrayTM for Genome-Wide Functional Analyses Rockville, MD August 1, 2005 – OriGene Technologies Inc. today announced that Eisai London Research Laboratories has licensed OriGene’s FlagArray platform for high-throughput drug target discovery. "We are pleased to formalize our relationship with OriGene,” said Yukio N

Untitled

CH-8010 Zürich Bahnhofstrasse 36 Postfach Telefon +41 (0) 58 888 5578 Telefax +41 (0) 58 888 4970 www.juliusbaer.com 13. Oktober 2005 Aus der Politik Als der Vorhang nach dem bewegten ersten Akt des deutschen Nachwahl- dramas endlich fiel, waren drei Dinge klar: Erstens wird Gerhard Schröder definitiv von der bundespolitischen Bühne abtreten, zweitens dürfte die CDU-Vorsitze

Copyright © 2010-2014 Medical Pdf Articles